Sitemap

• Home
• Science
  • Cutting Edge Science
    • Benign Prostate Hyperplasia (BPH)
      • 2022
        • Patient centred approach: LUTS & benign prostatic hypertrophy
    • Neurology
      • 2022
        • Dual Antiplatelet Therapy for IS or TIA within 24 hours
    • Cardiovascular
      • Thrombosis
        • 2022
          • Awareness of venous thromboembolism among patients with cancer
          • Effective and safe dose of LMWH for treatment of cancer-associated thrombosis (CAT)
          • Thromboprophylaxis in COVID19 pateint by Prof.Carrier. Interactive interview.
          • Prof Le Gal's session "Thromboprophylaxis in Acute Medical Illness"
          • Risk-stratified thromboprophylaxis in special patient groups
          • Real-world in-hospital antiplatelet-switching strategy after coronary interventions: The SWITCH study
          • Extended anticoagulation treatment for cancer-associated VTE
      • Dyslipidemia
        • 2022
          • Lp(a) in clinical practice
        • 2023
          • EAS/ESC guidelines set new targets for LDL-C, with lower levels reducing CV event rates.
      • Atherothrombosis
        • 2022
          • Antiplatelets in high bleeding risk in hospitalized patients with ACS
        • 2023
          • Meta-analysis of 8 studies on DAPT in elderly CAD patients published 2007-2020.
    • Central Nervous System
      • 2022
        • The Art of Risk Management
        • Criteria for the diagnosis of drug resistance epilepsy.
        • Why does seizure still persist? A consideration before stepping up treatment
        • Timing is everything
        • Medical Management of SE: ER to ICU
    • Chronic Kidney Disease
      • 2022
        • Is hyperphosphatemia a key link to higher risk of CVD in CKD patients?
    • Consumer health
      • Allergy
        • 2022
          • World Allergy Congress (WAC) 2019 Symposium Highlights
          • Clinical review on Efficacy of Fexofenadine in CIU
      • Digestive
        • 2022
          • The Important of Steatosis in the Paradigm Shift : from NAFLD to MAFLD
          • 4-strains Bacillus clausii: the adjunct therapy for acute kid's diarrhea treatment
    • Diabetes
      • 2022
        • Glycemic variability is an issue for DM patients
        • Fasting during Ramadan in T2DM patients
        • Balancing glucose control & hypoglycemia in T2DM & CKD
        • Unmet need for HbA1c target achievement with premix insulin
        • T1DM is associated with cognitive dysfunction
        • Asian T2DM patients may benefit from PPG control
        • Simultaneous initiation had better glucose control
        • Benefits and applications of TIR diabetes care
        • Real world data on insulin treatment trends
        • Commemorating insulin’s revolutionary discovery
        • Make a difference in T2DM management
      • 2023
        • Simplifying the complex insulin regimen
        • Why Ramadan Nutrition Plan matters in T2D?
    • Thrombosis
      • 2022
        • Personalized approach for cancer-associated thrombosis (CAT) management
      • 2023
        • What we should know about VTE prophylaxis in general surgical patients?
        • The management of antithrombotic treatments in thrombocytopenic patients with cancer
    • Vaccines
      • Childhood
        • 2022
          • Choose aP vaccines for improved parents' satisfaction
          • aP vs wP pertussis vaccines
          • 2-dose or 3-dose pre-exposure rabies prophylaxis among Thai children
        • 2023
          • Hexavalent Vaccine Benefits From Continuous Innovations For Children And For Your Practice
      • Influenza
        • 2022
          • Influenza vaccine in heart failure patients
          • WHO recommended composition of influenza virus vaccines for use in the Northern hemisphere 2022-2023
        • 2023
          • WHO recommended composition of influenza virus vaccines for use in the 2023 southern hemisphere
  • Events
    • Upcoming Events
      • Past, Present and Future of LMWH role in Cancer-Associaed Thrombosis and What is Biosimilarily for Biological product.
    • Past Events
      • Cardiovascular
        • 2023
          • ACC 2023 together with WCC
      • Central Nervous System
        • 2022
      • Diabetes
        • 2022
          • EASD 2022
          • Diabetes 360: Empowering patients to live well with Diabetes
        • 2023
          • 16th International Conference on Advanced Technologies & Treatments for Diabetes
    • Pre-Recorded webinar
      • Central Nervous System
        • 2022
          • EPILEPSY WEBINAR SERIES: Episode 4 - Comprehensive Series of Childhood Onset Epilepsy (Part 1)
          • EPILEPSY WEBINAR SERIES: Episode 4 - Comprehensive Series of Childhood Onset Epilepsy (Part 2)
          • EPILEPSY WEBINAR SERIES: Episode 4 - Comprehensive Series of Childhood Onset Epilepsy (Part 3)
          • EPILEPSY WEBINAR SERIES: Episode 4 - Comprehensive Series of Childhood Onset Epilepsy (Part 4)
          • EPILEPSY WEBINAR SERIES: Episode 5 - A Pharmacological Series
          • EPILEPSY WEBINAR SERIES: Episode 6 - A Drug-Resistant Epilepsy Series
          • EPILEPSY WEBINAR SERIES: Episode 7 - A Special Population Series
          • EPILEPSY WEBINAR SERIES: Episode 8 - A Series of Standard vs New Anti-Seizure Medications
          • EPILEPSY WEBINAR SERIES: Episode 9 - A Series of Epilepsy Comorbidities
          • EPILEPSY WEBINAR SERIES: Episode 10 - A Series of Interesting Case Discussion
          • EPILEPSY WEBINAR SERIES: Episode 11 - Misdiagnosis of Epilepsy Series
          • EPILEPSY WEBINAR SERIES: Episode 12 - Medical Management of SE: ER to ICU
          • EPILEPSY WEBINAR SERIES: Episode 13 - SUDEP: what we should know on classification & risk
      • Diabetes
        • 2022
          • 3rd Diabetes Asia Webinar: ADA2022 Highlight I
          • 3rd Diabetes Asia Webinar: ADA2022 Highlight II
          • 3rd Diabetes Asia Webinar: ADA2022 Highlight III
• Patient Support
  • Resources and Tools
    • Diabetes Solutions Beyond Medicines
    • Empower patient program
    • Simplify the start and titration insulin with innovative tool
  • Innovating in Patient Support
    • Atopic Dermatitis
      • 2022
        • A Story of Patient Living with Atopic Dermatitis
    • Consumer Healthcare
      • Allergy
        • 2022
          • Expert guidance on managing Allergies and Asthma during and after Covid-19
    • Rare Disease
      • 2022
        • A Story of Patient Living with Late-Onset Pompe Disease (LOPD)
        • A Story of Patient Living with Infantile-Onset Pompe Disease (IOPD)
        • A Story of Patient Living with Mucopolysaccharidosis Type 1 (MPS1)
        • A Story of Patient Living with Gaucher Disease
• Products
  • GENERAL MEDICINES
    • CLEXANE^®
    • PLAVIX^®
    • PRALUENT^®
    • RENVELA^®
    • DEPAKINE^®
    • XATRAL^®
    • SOLIQUA^®
    • TOUJEO^®
  • Specialty Care
  • Vaccines
    • SOLIQUA
    • TOUJEO
    • VAXIGRIPTETRA
    • Hexaxim
    • Pentaxim
    • Tetraxim
    • Adacel
    • Dengvaxia
    • Verorab
    • Imojev
    • Avaxim 80 U
    • Avaxim 160 U
    • Menactra
    • Stamaril
    • Typhim Vi
  • CONSUMER HEALTHCARE
• Cookie Policy - Cookie Policy
• Terms of Use - Terms of Use
• Email & Phone subscription PDPN
• Registration
• My Account
• Login
• Search